Wild Bioscience Expands Milton Park Operations

Key Takeaways

• Raised $60 million Series A led by Ellison Institute
• Expanded Milton Park to 16,000 sq ft, tripling plant output
• AI‑driven platform focuses on precision‑bred wheat for climate resilience
• Partnerships added with The Traits Company, KWS, Dyson Farming, Pairwise
• Lisa Flashner joins board; Dr Stuart Harrison becomes chief business officer

Pulse Analysis

The surge of venture capital into agricultural biotechnology reflects mounting pressure to safeguard food supplies against climate volatility. Wild Bioscience’s $60 million Series A, anchored by the Ellison Institute, underscores a broader market belief that AI‑enhanced breeding can outpace traditional methods. By integrating computational trait modeling with molecular editing, the company aims to shorten the cultivar development cycle, a competitive edge that investors are eager to back.

Milton Park’s expanded 16,000 sq ft footprint now houses a CL2‑rated gene‑editing laboratory and dedicated growth chambers, allowing Wild Bioscience to triple its plant output within months. This physical scaling translates directly into faster seed production for field trials, especially for its flagship precision‑bred wheat. The wheat focus is strategic: as the world’s most cultivated cereal, improvements in yield stability and carbon efficiency can generate measurable climate benefits and open sizable market opportunities across temperate regions.

Beyond labs, Wild Bioscience is weaving a global partnership web that includes The Traits Company, KWS, Dyson Farming and Pairwise Plants, accelerating pathway to market and distribution. The recent board addition of Lisa Flashner and the appointment of Dr Stuart Harrison as chief business officer bring deep industry and venture expertise, reinforcing the company’s commercial readiness. Together, the funding, infrastructure, and leadership upgrades position Wild Bioscience to become a leading supplier of climate‑resilient seeds, a sector projected to attract billions in investment over the next decade.